fromNature
1 week agoMicrobiota-driven antitumour immunity mediated by dendritic cell migration - Nature
Immune checkpoint blockade (ICB) therapies have improved survival rates in cancer patients, but low complete response rates necessitate the identification of predictive biomarkers and new strategies to overcome resistance.
Cancer